Sean Ianchulev, MD, MPH
Dr. Ianchulev is the Chief Medical Officer and VP of Medical Affairs and Business Development at Transcend Medical, a venture-backed company developing next-generation microstent technology for glaucoma. He is also a managing partner at Private Medical Equity, a private equity firm for managed direct investments. Dr. Ianchulev is also the inventor of intraoperative aberrometry and one of the lead developers of Lucentis. He is the founding member of several corporate boards as well as Associate Clinical Professor of Ophthalmology at UCSF. He has multiple high-impact publications in the field, which have been cited by more than 1,500 peer-reviewed publications. Dr. Ianchulev received his medical degree and a master’s of public health from Harvard University and completed his specialty training at the Doheny Eye Institute.